CHEN ISAN 4
4 · Tyra Biosciences, Inc. · Filed Sep 17, 2021
Insider Transaction Report
Form 4
CHEN ISAN
Director
Transactions
- Conversion
Series A Preferred Stock
2021-09-17−16,366→ 0 total→ Common Stock (42,509 underlying) - Conversion
Common Stock
2021-09-17+61,444→ 192,783 total - Conversion
Series B Preferred Stock
2021-09-17−7,290→ 0 total→ Common Stock (18,935 underlying)
Footnotes (2)
- [F1]On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
- [F2]Includes 37,105 shares subject to repurchase by us, which are subject to vesting.